Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
CING
Stock Latest News
Ratings
Cingulate Inc’s Strategic Progress and Promising Clinical Results Justify Buy Rating
4d ago
CING
Premium
The Fly
Cingulate completes pre-NDA meeting with FDA on NDA for CTx-1301
4d ago
CING
Premium
Company Announcements
Cingulate Inc. Reports 2024 Financial and Development Milestones
10d ago
CING
Premium
The Fly
Cingulate sees cash runway sufficient into Q4
11d ago
CING
Premium
Ratings
Promising Prospects for Cingulate Inc.: Buy Rating Backed by Positive Phase 3 Results and Market Potential of CTx-1301
1M ago
CING
Premium
Pre-Earnings
Cingulate, Inc. (CING) Q4 Earnings Cheat Sheet
1M ago
CING
Premium
Company Announcements
Cingulate Inc. Advances Towards FDA Approval for CTx-1301
1M ago
8K
CING
Premium
The Fly
Cingulate reports safety results from final Phase 3 trials for CTx-1301
1M ago
CING
Premium
The Fly
Cingulate price target adjusted to $20 from $8 at H.C. Wainwright
2M ago
CING
Premium
The Fly
Cingulate initiated with a Buy at Roth MKM
3M ago
CING
Premium
Company Announcements
Cingulate Inc Completes Key FDA Study for ADHD Drug
3M ago
8K
CING
Premium
The Fly
Cingulate completed final FDA-required study for CTx-1301 for ADHD
3M ago
CING
Premium
Company Announcements
Cingulate Inc Secures $5M Financing for Strategic Growth
3M ago
8K
CING
Premium
The Fly
Cingulate completes financing transaction for net proceeds of $5M
3M ago
CING
Premium
The Fly
Cingulate upgraded to Buy from Hold at Maxim
5M ago
CING
Premium
The Fly
Cingulate reports Q3 net loss $3.2M vs. $5.98M last year
5M ago
CING
Premium
The Fly
Cingulate sees cash runway into 3Q25
5M ago
CING
Premium
The Fly
Cingulate files to sell 1.5M shares of common stock for holders
6M ago
CING
Premium
Company Announcements
Cingulate Inc: Executive Pay Restored, Funding Up, FDA Study Launched
7M ago
8K
CING
Premium
The Fly
Cingulate initiates final study for ADHD asset CTx-1301
7M ago
CING
Premium
The Fly
Cingulate Inc trading resumes
8M ago
CING
Premium
The Fly
Cingulate Inc trading halted, volatility trading pause
8M ago
CING
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.